About the Rogel Cancer Center

Radiation oncologist with a patient

Nationally Recognized Cancer Care

Researching ways to prevent cancer, create better treatments and improve quality of life and outcomes for cancer patients and survivors

The Rogel Cancer Center is one of an elite number of programs across the country designated a “comprehensive cancer center” by the National Cancer Institute, a recognition of our excellence in collaborative state-of-the-art cancer research that impacts how cancer is prevented, diagnosed and treated.

Our patient care is consistently rated No. 1 in Michigan and among the best in the nation by U.S. News & World Report. As part of the National Comprehensive Cancer Network, our faculty help set national guidelines for cancer care.

 

The Conquest of Cancer Through Research

The University of Michigan spends the second-highest amount on research of all universities in the United States. It is a broad and deep university with unmatched talent in science, medicine and the humanities. As part of the fabric of the vibrant and diverse research happening across the institution, our cancer center takes advantage of the unique collaborations in our many top-ranked schools and colleges. We can harness innovation by engaging disciplines that are not typically thought to be central to attacking the cancer problem (including faculty in fields like engineering and mathematics), as well as through more traditional collaborations between faculty in medicine, public health, nursing and social work.

Learn more about research at the Rogel Cancer Center.

 

Training the Next Generation of Clinicians and Researchers

In cooperation with the world-renowned U-M Medical School, we are dedicated to educating and training the next generation of oncologists and oncology researchers through fellowship programs, graduate training programs, and postdoctoral programs. The Medical School was the University's first professional school, and since graduating its first class of six students in 1851 — a group which paid a mere $5 for two years of medical education — we have become a leader in preparing the physicians and scientists of the future.

Our students are involved in many research activities, and are given the freedom and resources to pursue those lines of inquiry that are of greatest interest to them. Many will play a crucial role in discoveries that will make an impact worldwide. Our students also play a key role our mission to provide excellence in patient care.

Learn more by visiting our Education and Training page.

News & Stories

Family with mom and dad and three kids sitting on a park bench, dad's arms extended around the family.
Health Lab

Intuition pushed mom to keep checking for breast cancer

Michigan mom had no reason to suspect cancer. But instinct nudged her to find out for sure — and carried her through challenging treatments to remission.
Three people stand arm in arm with backs to camera studying a wall of family mementos
Health Lab

Online resources and coaching helped people seek genetic testing for cancer

New study from researchers at the University of Michigan Rogel Cancer Center showed an online resource and phone-based coaching both helped increase rates of genetic testing.
pattern up close sequencing gene navy yellow
Health Lab

Comprehensive DNA sequencing reveals hidden drivers of cancer

Two research papers describe how long-read nanopore sequencing can detect alterations in cancer cells that might be missed by conventional sequencing.
cancer cell blue yellow
Health Lab

‘Molecular glue’ stabilizes protein that inhibits development of non-small cell lung cancer and uterine cancer

University of Michigan researchers found a new protein target PP2A and developed a drug to treat non-small cell lung cancers that have KRAS mutations.
man smiling with glasses in booth
Health Lab

Exceptional response to immunotherapy gives patient with liver cancer more milestones to celebrate

U-M Health Rogel Cancer Center used single-dose immunotherapy and transplant oncology to treat advanced hepatocellular carcinoma in a 69-year-old patient.
red blood cells going through clear tube red background
Health Lab

FDA-approved drug offers hope for patients with polycythemia vera, a rare bone marrow disorder

FDA-approved rusfertide offers new hope for polycythemia vera patients by reducing phlebotomy dependence, easing symptoms, and improving daily life.